The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

被引：1089

作者：

Dignass, A. ^{[1
]}

Van Assche, G. ^{[16
]}

Lindsay, J. O. ^{[9
]}

Lemann, M. ^{[8
]}

Soderholm, J. ^{[13
]}

Colombel, J. F. ^{[2
]}

Danese, S. ^{[3
]}

D'Hoore, A. ^{[4
]}

Gassull, M. ^{[5
]}

Gomollon, F. ^{[6
]}

Hommes, D. W. ^{[7
]}

Michetti, P. ^{[10
]}

O'Morain, C. ^{[11
]}

Oresland, T. ^{[12
]}

Windsor, A. ^{[17
]}

Stange, E. F. ^{[14
]}

Travis, S. P. L. ^{[15
]}

机构：

[1] Markus Krankenhaus, Dept Med 1, D-60431 Frankfurt, Germany

[2] Hosp Huriez, Lille, France

[3] Ist Clin Humanitas, Milan, Italy

[4] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

[5] Germans Trias & Pujol Fdn, Badalona, Spain

[6] Hosp Clin Univ, Zaragoza, Spain

[7] Leiden Univ, Med Ctr, Leiden, Netherlands

[8] Hosp St Louis, Paris, France

[9] Barts & London NHS Trust, London, England

[10] Gastroenterol La Source Beaulieu, Lausanne, Switzerland

[11] Adelaide & Meath Hosp, Dublin, Ireland

[12] Akershus Univ Hosp, Lorenskog, Norway

[13] Linkoping Univ Hosp, S-58185 Linkoping, Sweden

[14] Robert Bosch Krankenhaus, Stuttgart, Germany

[15] John Radcliffe Hosp, Oxford OX3 9DU, England

[16] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium

[17] Univ Coll London Hosp, London, England

来源：

JOURNAL OF CROHNS & COLITIS | 2010年 / 4卷 / 01期

关键词：

Crohn's disease; Mesalazine; Steroids; Budesonide; Azathioprine; Infliximab; Adalimumab; Surgery; INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; POUCH-ANAL ANASTOMOSIS; DOUBLE-BLIND TRIAL; LAPAROSCOPIC ILEOCECAL RESECTION; STEROID-INDUCED REMISSION; POPULATION-BASED COHORT; NECROSIS-FACTOR-ALPHA; TO-END ANASTOMOSIS; QUALITY-OF-LIFE;

D O I：

10.1016/j.crohns.2009.12.002

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：28 / 62

页数：35

共 288 条

[1] Corticosteroids and immunomodulators: Postoperative infectious complication risk in inflammatory bowel disease patients [J].

Aberra, FN ;

Lewis, JD ;

Hass, D ;

Rombeau, JL ;

Osborne, B ;

Lichtenstein, GR .

GASTROENTEROLOGY, 2003, 125 (02) :320-327

[2] CONTROLLED TRIAL OF ANTIMYCOBACTERIAL THERAPY IN CROHNS-DISEASE - CLOFAZIMINE VERSUS PLACEBO [J].

AFDHAL, NH ;

LONG, A ;

LENNON, J ;

CROWE, J ;

ODONOGHUE, DP .

DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (04) :449-453

[3] Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease [J].

Akobeng, AK ;

Gardener, E .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01)

[4]

Akobeng AK, 2007, COCHRANE DB SYST REV, V3

[5]

Alfadhli AA, 2003, COCHRANE DB SYST REV

[6] SEGMENTAL COLONIC RESECTION IS AN APPROPRIATE OPERATION FOR SHORT SKIP LESIONS DUE TO CROHNS-DISEASE IN THE COLON [J].

ALLAN, A ;

ANDREWS, H ;

HILTON, CJ ;

KEIGHLEY, MRB ;

ALLAN, RN ;

ALEXANDERWILLIAMS, J .

WORLD JOURNAL OF SURGERY, 1989, 13 (05) :611-616

[7] Factors that predict conversion in 69 consecutive patients undergoing laparoscopic ileocecal resection for Crohn's disease: A prospective study [J].

Alves, A ;

Panis, Y ;

Bouhnik, Y ;

Marceau, C ;

Rouach, Y ;

Lavergne-Slove, A ;

Vicaut, E ;

Valleur, P .

DISEASES OF THE COLON & RECTUM, 2005, 48 (12) :2302-2308

[8] Preparation and characterisation of linear dextrins and their use as substrates in in vitro studies of starch branching enzymes [J].

Andersson, L ;

Rydberg, U ;

Larsson, H ;

Andersson, R ;

Åman, P .

CARBOHYDRATE POLYMERS, 2002, 47 (01) :53-58

[9]

[Anonymous], 2001, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD002913

[10]

[Anonymous], GASTROENTEROLOGY S1

← 1 2 3 4 5 6 7 8 9 10 →